Knowledge Enhancement on Lung Cancer and the Disease Prevention for People of Selokaton, Gondangrejo, Karanganyar

Mirah Rejeki(1*), Umi Kartikawati(2)

(1) Universitas Kusuma Husada Surakarta
(2) Universitas Kusuma Husada Surakarta
(*) Corresponding Author


Degenerative Disease contributes 63% of dead worldwide. It counts for 36 million people’s death every year. The prevalence number of the disease in Indonesia increases constantly. Lifestyle and food consumption habit are identified as two reasons why the disease takes place. One type of the diseases is cancer, where according to the data of World Health Organization, this is the second highest reason of death after cardiovascular disease. Type of cancer with the highest incidence and the top reason of death is lung cancer. In Karanganyar, according to the Health Department data, the occurrence of lung cancer increased from 1 case in 2016 to 5 cases in 2017. This increment alerts the urgent need for prevention and treatment of the disease. The lack of knowledge about lung cancer is the main reason leading to a possible high prevalence number. Based on the situation, the people knowledge about the lung cancer needs to be enhanced. This community development program was set up to achieve that objective through activity of presentation, discussion, and consultation. It involved 36 people in the age of 30-65 year old selected by the local government of Selokaton. The knowledge improvement of the attendees was assessed using pre-test and post-test. It was measured that the knowledge of participants increases from 4.58 at pre-test to 8.53 at post-test. This may indicate their interest on the program. It is expected that their knowledge will motivate then changing lifestyle in order to prevent the disease.


Degenerative Disease, Lung Cancer, Knowledge Enhancement, Community Development


Abdel-Daim, M. M., El-Tawil, O. S., Bungau, S. G., & Atanasov, A. G. (2019). Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach. Oxidative Medicine and Cellular Longevity, 2019, 1–3.

Ananda, R. R., Ermayanti, S., & Abdiana, A. (2018). Hubungan Staging Kanker Paru dengan Skala Nyeri pada Pasien Kanker Paru yang Dirawat di Bagian Paru RSUP DR M Djamil Padang. Jurnal Kesehatan Andalas, 7(3), 430–435.

Cufari, M. E., Proli, C., De Sousa, P., Raubenheimer, H., Al Sahaf, M., Chavan, H., Shedden, L., Niwaz, Z., Leung, M., Nicholson, A. G., Anikin, V., Beddow, E., McGonigle, N., Dusmet, M. E., Jordan, S., Ladas, G., & Lim, E. (2017). Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK. European Journal of Cancer (Oxford, England: 1990), 84, 55–59.

Dela Cruz, C. S., Tanoue, L. T., & Matthay, R. A. (2011). Lung Cancer: Epidemiology, Etiology, and Prevention. Clinics in Chest Medicine, 32(4).

Giaj Levra, M., Cotté, F.-E., Corre, R., Calvet, C., Gaudin, A.-F., Penrod, J. R., Grumberg, V., Jouaneton, B., Jolivel, R., Assié, J.-B., & Chouaïd, C. (2020). Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis. Lung Cancer, 140, 99–106.

Haaf, K. ten. (2015, September). Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?.

Jeon, J., Holford, T. R., Levy, D. T., Feuer, E. J., Cao, P., Tam, J., Clarke, L., Clarke, J., Kong, C. Y., & Meza, R. (2018). Smoking and Lung Cancer Mortality in the United States From 2015 to 2065. Annals of Internal Medicine, 169(10), 684–693.

Kementerian Kesehatan. (2019). Profil Kesehatan Indonesia 2018 [Indonesia Health Profile 2018] (p. 207).

Lin, K.-F., Wu, H.-F., Huang, W.-C., Tang, P.-L., Wu, M.-T., & Wu, F.-Z. (2017). Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer. BMC Pulmonary Medicine, 17(1), 120.

Luo, Q., Steinberg, J., O’Connell, D. L., Yu, X. Q., Caruana, M., Wade, S., Pesola, F., Grogan, P. B., Dessaix, A., Freeman, B., Dunlop, S., Sasieni, P., Blakely, T., Banks, E., & Canfell, K. (2019). Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? Lung Cancer, 130, 208–215.

Malhotra, J., Malvezzi, M., Negri, E., La Vecchia, C., & Boffetta, P. (2016). Risk factors for lung cancer worldwide. The European Respiratory Journal, 48(3), 889–902.

Polanski, J., Jankowska-Polanska, B., Rosinczuk, J., Chabowski, M., & Szymanska-Chabowska, A. (2016). Quality of life of patients with lung cancer. OncoTargets and Therapy, 9, 1023–1028.

Putra, A. C., Nurwidya, F., Andarini, S., Zaini, J., Syahruddin, E., Hudoyo, A., & Jusuf, A. (2015). Masalah Kanker Paru pada Lanjut Usia. 42(11), 5.

Rahal, Z., El Nemr, S., Sinjab, A., Chami, H., Tfayli, A., & Kadara, H. (2017). Smoking and Lung Cancer: A Geo-Regional Perspective. Frontiers in Oncology, 7.

Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, Lucian. R., Dacic, S., Duhig, E., Flieder, D. B., Geisinger, K., Hirsch, F. R., Ishikawa, Y., Kerr, K. M., Noguchi, M., Pelosi, G., Powell, C. A., Tsao, M. S., & Wistuba, I. (2015). The 2015 World Health Organization Classification of Lung Tumors. Journal of Thoracic Oncology, 10(9), 1243–1260.

Weiderpass, E. (2010). Lifestyle and Cancer Risk. Journal of Preventive Medicine and Public Health, 43(6), 459.

WHO. (2019a). Cancer.

WHO, 2019. (2019b, May 29). WHO highlights huge scale of tobacco-related lung disease deaths.

Article Metrics

Abstract view(s): 318 time(s)
PDF (Bahasa Indonesia): 253 time(s)


  • There are currently no refbacks.